- Home
- ABTS vs ALBT Comparison
ABTS vs ALBT Comparison
Compare ABTS & ALBT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | ABTS | ALBT |
|---|---|---|
| Founded | 2010 | 2014 |
| Country | Hong Kong | United States |
| Employees | N/A | N/A |
| Industry | Computer Software: Programming Data Processing | Biotechnology: Biological Products (No Diagnostic Substances) |
| Sector | Technology | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 4.0M | 3.3M |
| IPO Year | 2021 | 2015 |
Fundamental Metrics
Financial Performance| Metric | ABTS | ALBT |
|---|---|---|
| Price | $1.10 | $0.34 |
| Analyst Decision | | |
| Analyst Count | 0 | 0 |
| Target Price | N/A | N/A |
| AVG Volume (30 Days) | ★ 4.8M | 367.9K |
| Earning Date | 04-29-2026 | 08-14-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | ★ 33.18 |
| EPS | ★ N/A | N/A |
| Revenue | N/A | N/A |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | N/A | N/A |
| P/E Ratio | N/A | ★ N/A |
| Revenue Growth | ★ N/A | N/A |
| 52 Week Low | $0.76 | $0.21 |
| 52 Week High | $10.86 | $4.74 |
Technical Indicators
Market Signals| Indicator | ABTS | ALBT |
|---|---|---|
| Relative Strength Index (RSI) | 43.98 | 45.30 |
| Support Level | $0.89 | $0.34 |
| Resistance Level | $1.63 | $0.41 |
| Average True Range (ATR) | 0.53 | 0.04 |
| MACD | -0.05 | 0.00 |
| Stochastic Oscillator | 2.20 | 50.56 |
Price Performance
Historical ComparisonAbout ABTS Abits Group Inc
Abits Group Inc is a bitcoin mining company. The Company operates self-owned and hosted bitcoin mining facilities in Tennessee, United States.
About ALBT Avalon GloboCare Corp.
Avalon Globocare Corp is an intelligent biotech developer and healthcare service provider dedicated to promoting and empowering high-impact, transformative biotechnology, clinical applications, and healthcare facility management. The company has two reportable segments: the real property operating segment, which is the key revenue driver, and the laboratory testing services segment. The company focuses on diagnostic and therapeutic areas like early detection of oral cancer, ovarian cancer, kidney cancer, skin regeneration and anti-fibrosis, and treatments of degenerative disorders.